References
- Ministerul Sanatatii Publice, Institutul National de Transfuzie Sanguina. Ghidul national de utilizare terapeutica rationala a sangelui si a componentelor sanguine umane. Bucuresti: INHT; 2007.
- Purcaru F, Novac M, Stoica M, Cernea D. Derivatele de sante in terapie intensiva Caracteristici. Indicatii. Complicatii. 2012.
- Barriteau CM, Bochey P, Lindholm PF, Hartman K, Sumugod R, Ramsey G. Blood transfusion utilization in hospitalized COVID-19 patients. Transfusion. 2020 Sep;60(9):1919-23.
- Cabo J, Brochier A, Saussoy P, van Dievoet MA, Capirchio L, Delire B, et al. Positive direct antiglobulin test in COVID-19 patients: Decision-making process. Transfus Clin Biol. 2021 Nov;28(4):414-9.
- Perelman I, Fergusson D, Lampron J, Mack J, Rubens F, Giulivi A, et al. Exploring Peaks in Hospital Blood Component Utilization: A 10-Year Retrospective Study at a Large Multisite Academic Centre. Transfus Med Rev. 2021 Jan;35(1):37-45.
- Vries Rd, Haas F. Blood Transfusion Guideline. Utrecht: CBO; 2012.
- Garcia-Erce JA, Romon-Alonso I, Jerico C, Domingo-Morera JM, Arroyo-Rodriguez JL, Sola-Lapena C, et al. Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals. Int J Environ Res Public Health. 2021 Mar 27;18(7)
- Velazquez-Kennedy K, Luna A, Sanchez-Tornero A, Jimenez-Chillon C, Jimenez-Martin A, Valles Carboneras A, et al. Transfusion support in COVID-19 patients: Impact on hospital blood component supply during the outbreak. Transfusion. 2021 Feb;61(2):361-7.
- Cabo J, Brochier A, Saussoy P, van Dievoet MA, Capirchio L, Delire B, et al. Positive direct antiglobulin test in COVID-19 patients: Decision-making process. Transfus Clin Biol. 2021 Nov;28(4):414-9.
- Pessoni LL, Ferreira MA, Silva JCRd, Alcântara KCd. Red blood cell alloimmunization among hospitalized patients: transfusion reactions and low alloantibody identification rate. Hematology, Transfusion and Cell Therapy. 2018;40(4):326-31.